MORE►
TAMU
Topping out ceremony for Texas A&M Fort Worth's Law and Education Building [Photo: TAMU]
The Last Word: John Goff on ‘Topping Out’ Texas A&M-Fort Worth’s Law and Education Building
by David Seeley | Nov 13, 2024
Texas A&M is putting a major stamp on downtown Fort Worth, thanks to a $350 million research campus under construction in the Panther City. On Monday, a milestone was marked 250 feet above the future site of Texas A&M Fort Worth, which is slated to become a major hub for education, research, and innovation for years to come.
Related Articles
Calendar: Not-to-Miss Events for Innovators in Dallas-Fort Worth
Apply Now:
Opportunities for North Texas Innovators UTD Team and CorroHealth Use AI ‘Reasoning’ for Medical Coding Automation OK2BX To Host 4th Annual Film Festival at Angelika Dallas, Adds College Fair and Workshops The Last Word: On UTD Being Redesignated as a National Center of Academic Excellence in Cybersecurity
Opportunities for North Texas Innovators UTD Team and CorroHealth Use AI ‘Reasoning’ for Medical Coding Automation OK2BX To Host 4th Annual Film Festival at Angelika Dallas, Adds College Fair and Workshops The Last Word: On UTD Being Redesignated as a National Center of Academic Excellence in Cybersecurity
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
